Ambar Protein Industries announces Q2 results: Profit Rises by 244.87% YoY

The comprehensive analytics outlining the performance and outlook of Ambar Protein Industries Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Ambar Protein Industries Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 29.64 %. However, it did see a marginal slip of -4.4 % from the previous quarter. Expenses decreased slightly by -5.96 % quarter-on-quarter, aligning with the annual rise of 26.37 %. Operating profit, while up 170.51 % compared to last year, faced a quarter-on-quarter increase of 43.54 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.47 %, but an expansion of 1.58 % sequentially. Other income rose by 3.21 % compared to the last quarter, despite an annual growth of 89.08 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year decrease remains at a moderate -11.11 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 23.08 %. Profit before tax grew annually by 351.9 % but saw an increase from the preceding quarter by 56.58 %.
Tax expenses as a percentage of profits increased slightly by 22.16 % compared to last year, with a more notable quarter-on-quarter increase of 0.22 %. Net profit rose by 244.87 % year-on-year but experienced a 56.4 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 240.88 % but a quarterly rise of 55.67 %. In summary, Ambar Protein Industries Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Ambar Protein Industries Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 29.64 % year-on-year growth, although there was a slight dip of -4.4 % from the previous quarter. Expenses rose by 26.37 % compared to the previous year, with a decrease of -5.96 % quarter-on-quarter. Operating Profit surged by 170.51 % annually, and saw a 43.54 % increase from the last quarter.
Net Profit showed yearly increase of 244.87 %, and experienced a 56.4 % increase from the previous quarter. Earnings Per Share (EPS) rose by 240.88 % annually, however rose by 55.67 % compared to the last quarter. In essence, while Ambar Protein Industries Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.